{'52WeekChange': 1.0218341,
 'SandP52WeekChange': 0.0644362,
 'address1': '3471 River Hills Drive',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 23.15,
 'askSize': 1200,
 'averageDailyVolume10Day': 392750,
 'averageVolume': 877768,
 'averageVolume10days': 392750,
 'beta': 0.92549,
 'beta3Year': None,
 'bid': 20,
 'bidSize': 900,
 'bookValue': 4.775,
 'category': None,
 'circulatingSupply': None,
 'city': 'Cincinnati',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 23.57,
 'dayLow': 22.63,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': 0.319,
 'enterpriseToEbitda': 21.043,
 'enterpriseToRevenue': 4.885,
 'enterpriseValue': 996628672,
 'exDividendDate': 1548979200,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '513-271-3702',
 'fiftyDayAverage': 21.255428,
 'fiftyTwoWeekHigh': 25.88,
 'fiftyTwoWeekLow': 5.51,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 39202346,
 'forwardEps': 1.01,
 'forwardPE': 22.920792,
 'fromCurrency': None,
 'fullTimeEmployees': 660,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.011670001,
 'heldPercentInstitutions': 0.87157,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1569801600,
 'lastMarket': None,
 'lastSplitDate': 1179100800,
 'lastSplitFactor': '3:2',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/meridianbioscience.com',
 'longBusinessSummary': 'Meridian Bioscience, Inc., a life science company, '
                        'develops, manufactures, distributes, and sells '
                        'diagnostic test kits primarily for various '
                        'gastrointestinal and respiratory infectious diseases, '
                        'and elevated blood lead levels worldwide. The company '
                        'operates through Diagnostics and Life Science '
                        'segments. The Diagnostics segment offers testing '
                        'platforms and technologies, including real-time PCR '
                        'amplification under the Revogene brand; isothermal '
                        'DNA amplification under the Alethia brand; rapid '
                        'fluorescence-based immunoassay platform under the '
                        'Curian brand; rapid single-use immunoassays under the '
                        'ImmunoCard and ImmunoCard STAT! brand names; '
                        'enzyme-linked immunoassays under the PREMIER brand; '
                        'and anodic stripping voltammetry, an electrical '
                        'chemical sensor platform for quantitative '
                        'determination under the LeadCare and PediaStat '
                        "brands. This segment's products are primarily used in "
                        'the detection of infectious diseases caused by '
                        'various bacteria, viruses, parasites, and pathogens. '
                        'Its products consists of gastrointestinal assays, '
                        'including tests for C. difficile, Enterohemorrhagic '
                        'E. coli, Campylobacter jejuni, H. pylori, '
                        'Cryptosporidium, giardia lamblia, and calprotectin; '
                        'respiratory illness assays, such as tests for Group A '
                        'Streptococcus, Influenza, M. pneumoniae, Bordetella '
                        'pertussis, and respiratory syncytial virus; blood '
                        'chemistry assays; and tests for Group B '
                        'Streptococcus, Chlamydia trachomatis, Neisseria '
                        'gonorrhea, Herpes Simplex Virus Type 1 and Type 2, '
                        'and Malaria. This segment sells its products through '
                        'direct sales force and independent distributors to '
                        'acute care hospitals, reference laboratories, '
                        'outpatient clinics, and physician office '
                        'laboratories. The Life Science segment offers bulk '
                        'antigens, antibodies, PCR/qPCR reagents, nucleotides, '
                        'and bioresearch reagents used by researchers, '
                        'agri-bio companies, and IVD manufacturing companies. '
                        'Meridian Bioscience, Inc. was incorporated in 1976 '
                        'and is headquartered in Cincinnati, Ohio.',
 'longName': 'Meridian Bioscience, Inc.',
 'market': 'us_market',
 'marketCap': 991581632,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_287401',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 21368000,
 'nextFiscalYearEnd': 1632960000,
 'open': 23.38,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 1.83,
 'phone': '513-271-3700',
 'previousClose': 23.63,
 'priceHint': 2,
 'priceToBook': 4.8481674,
 'priceToSalesTrailing12Months': 4.8606224,
 'profitMargins': 0.10474,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 23.57,
 'regularMarketDayLow': 22.63,
 'regularMarketOpen': 23.38,
 'regularMarketPreviousClose': 23.63,
 'regularMarketPrice': 23.38,
 'regularMarketVolume': 347447,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 42832900,
 'sharesPercentSharesOut': 0.0725,
 'sharesShort': 3104765,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 2664340,
 'shortName': 'Meridian Bioscience Inc.',
 'shortPercentOfFloat': 0.097600006,
 'shortRatio': 3.98,
 'startDate': None,
 'state': 'OH',
 'strikePrice': None,
 'symbol': 'VIVO',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': 0,
 'trailingAnnualDividendYield': 0,
 'trailingEps': 0.5,
 'trailingPE': 46.3,
 'twoHundredDayAverage': 13.048705,
 'volume': 347447,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.meridianbioscience.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '45244'}